PREVITALI, STEFANO CARLO
 Distribuzione geografica
Continente #
AS - Asia 3.253
NA - Nord America 3.191
EU - Europa 3.104
SA - Sud America 717
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 65
OC - Oceania 4
Totale 10.669
Nazione #
US - Stati Uniti d'America 3.043
RU - Federazione Russa 1.817
SG - Singapore 1.183
CN - Cina 1.048
BR - Brasile 617
IT - Italia 516
HK - Hong Kong 373
VN - Vietnam 300
FR - Francia 160
SE - Svezia 131
DE - Germania 110
GB - Regno Unito 106
IN - India 87
BD - Bangladesh 75
CA - Canada 66
NL - Olanda 59
AT - Austria 48
FI - Finlandia 48
MX - Messico 38
AR - Argentina 35
JP - Giappone 24
TR - Turchia 24
ZA - Sudafrica 23
ES - Italia 21
EC - Ecuador 19
IQ - Iraq 18
ID - Indonesia 17
PL - Polonia 17
JM - Giamaica 13
UZ - Uzbekistan 13
CO - Colombia 11
SA - Arabia Saudita 11
IE - Irlanda 10
PY - Paraguay 10
VE - Venezuela 9
IR - Iran 8
LT - Lituania 8
PK - Pakistan 8
CL - Cile 7
DZ - Algeria 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CR - Costa Rica 6
GR - Grecia 6
KE - Kenya 6
LB - Libano 6
MA - Marocco 6
TN - Tunisia 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
JO - Giordania 5
PS - Palestinian Territory 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
AU - Australia 4
GT - Guatemala 4
HN - Honduras 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
RO - Romania 4
BG - Bulgaria 3
BO - Bolivia 3
CG - Congo 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
SN - Senegal 3
TH - Thailandia 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
HT - Haiti 1
KR - Corea 1
Totale 10.324
Città #
Dallas 737
Singapore 566
Ashburn 422
Moscow 378
Hong Kong 369
San Jose 365
Council Bluffs 220
Beijing 166
Shanghai 165
Milan 155
Hefei 149
Lauterbourg 129
Ho Chi Minh City 118
New York 84
Orem 67
Los Angeles 65
São Paulo 61
Santa Clara 60
Hanoi 59
Lawrence 43
Princeton 43
Nuremberg 39
Rome 29
Chennai 28
Helsinki 28
Amsterdam 25
Chicago 24
Brooklyn 22
Denver 22
Montreal 22
Tokyo 22
Vienna 22
Washington 22
Boardman 21
Manchester 20
Phoenix 20
Poplar 19
Belo Horizonte 17
Munich 17
Toronto 17
Boston 16
Hangzhou 15
London 15
Mumbai 15
Shenzhen 15
Cesano Boscone 14
Guangzhou 14
Houston 14
Seattle 14
Warsaw 14
Bologna 13
Da Nang 13
Haiphong 13
Johannesburg 13
Lappeenranta 13
Rio de Janeiro 13
Zhengzhou 13
Atlanta 12
Curitiba 12
Biên Hòa 11
Falkenstein 11
Randolph Township 11
Brasília 10
Charlotte 10
Dublin 10
Frankfurt am Main 10
Naples 10
San Francisco 10
Tashkent 10
Ankara 9
Guayaquil 9
Stockholm 9
Assago 8
Brescia 8
Buffalo 8
Des Moines 8
Kingston 8
Mexico City 8
Salvador 8
Baghdad 7
Bengaluru 7
Buenos Aires 7
Santo André 7
Thái Bình 7
Vancouver 7
Asunción 6
Barnet 6
City of London 6
Fortaleza 6
Guarulhos 6
Miami 6
Nairobi 6
Omaha 6
Porto Alegre 6
Querétaro 6
Riyadh 6
San José 6
Skokie 6
Turku 6
Xi'an 6
Totale 5.436
Nome #
Multidisciplinary Screening of a Novel Founder LMNA Mutation Associated With Cardiomyopathy in a Geographic Isolate 284
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13 236
Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD 220
JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice 180
Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration 168
LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models 163
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 152
Jab1 regulates Schwann cell proliferation and axonal sorting through p27. 145
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 142
Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy 136
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy 131
Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis 127
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation 125
Overcoming therapeutic challenges: Successful management of a supposedly triple seronegative, refractory generalized myasthenia gravis patient with efgartigimod 121
A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy ameliorates hereditary spastic paraparesis due to spastin mutation. 120
Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon 9(4) (April 2023) e15047] (Heliyon (2023) 9(4), (S2405844023022545), (10.1016/j.heliyon.2023.e15047)) 116
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature 116
Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy 111
Prostaglandin D2 synthase modulates macrophage activity and accumulation in injured peripheral nerves 107
Charcot-Marie-Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases 103
Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy 103
A novel heat shock protein 27 homozygous mutation: widening of the continuum between MND/dHMN/CMT2 98
Begelomab for severe refractory dermatomyositis: A case report 98
The mitochondrial protease AFG3L2 is essential for axonal development 97
Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs 96
A GENOMIC APPROACH TO IDENTIFY NEW GENES RESPONSIBLE FOR INHERITED MOTOR AND CMT2 NEUROPATHIES: A COLLABORATIVE STUDY 95
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 93
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy 92
Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease 92
Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon Volume 9, Issue 4, April 2023, Article e15047](S2405844023022545)(10.1016/j.heliyon.2023.e15047) 92
Expanding the spectrum of genes responsible for hereditary motor neuropathies 91
CLINICAL AND MOLECULAR CHARACTERIZATION OF A COHORT OF PATIENTS WITH DISTAL MOTOR NEUROPATHY 87
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications 87
CLINICAL CHARACTERIZATION OF A PATIENT CARRYING HINT1 MUTATION 86
CHARCOT-MARIE-TOOTH DISEASE TYPE 4B: A MULTICENTRE RETROSPECTIVE STUDY 84
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 80
24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy 80
A 5-year clinical follow-up study from the Italian National Registry for FSHD 80
Correction to: Molecular mechanisms and therapeutic strategies for neuromuscular diseases (Cellular and Molecular Life Sciences, (2024), 81, 1, (198), 10.1007/s00018-024-05229-9) 77
Autocrine and immune cell-derived BDNF in human skeletal muscle: implications for myogenesis and tissue regeneration 76
Animal Models as a Tool to Design Therapeutical Strategies for CMT-like Hereditary Neuropathies 74
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 73
Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation 73
The extracellular matrix affects axonal regeneration in peripheral neuropathies 71
Abnormal Schwann cell-axon interaction in EBF-2 "knock out" mice 70
Vimentin regulates peripheral nerve myelination 69
Vocal cord paralysis in Charcot–Marie–Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: A case report and review of the literature 67
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 66
Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers. 66
Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-tooth type 4B1 neuropathy with myelin outfoldings 65
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold 65
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 64
DEFINING GENOTYPE-PHENOTYPE CORRELATIONS IN THE CMT NEUROPATHIES 64
Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies 63
Autoimmunity in the peripheral nervous system 63
A whole-brain functional network connectivity analysis in patients with hereditary and acquired peripheral neuropathy. 63
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 62
Facioscapulohumeral dystrophy 62
Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis 61
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy 61
LOSS OF FIG4 IN BOTH SCHWANN CELLS AND MOTOR NEURONS CONTRIBUTES TO CMT4J NEUROPATHY 60
Molecular mechanisms and therapeutic strategies for neuromuscular diseases. 59
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 59
CYTOSKELETON AND PERIPHERAL NERVE MYELINATION: A NOVEL ROLE FOR VIMENTIN 59
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 58
Expression analysis in the peripheral nerve of the myotubularin-related 2 protein phosphatase, mutated in CMT4B1 58
Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Stydy. 58
Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage 58
VOCAL CORD PARALYSIS IN CHARCOT-MARIE-TOOTH TYPE 4B1 DISEASE ASSOCIATED WITH A NOVEL MUTATION IN THE MYOTUBULARIN-RELATED PROTEIN 2 GENE: A CASE REPORT AND REVIEW OF THE LITERATUREPPP 57
A whole-brain network analysis in patients with hereditary and acquired peripheral neuropathy 57
CSN5/JAB1 PLAYS A ROLE IN AXONAL SORTING AND MYELINATION IN PERIPHERAL NERVE 57
Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination 57
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments 57
The exctracellular matrix affects axonal regeneration in peripheral neuropathies 57
Hypogonadotropic hypogonadism and peripheral neuropathy in Ebf2-null mice 57
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study 57
MODULATION OF NEUREGULIN 1 TYPE III PATHWAY TO TREAT HEREDITARY DEMYELINATING NEUROPATHIES 56
TRAFFICKING THROUGH THE ENDO-LYSOSOMAL AXIS REGULATES MYELINATION AND REPAIR IN THE PERIPHERAL NERVOUS SYSTEM 56
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 56
Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve 56
Muscle MRI findings in facioscapulohumeral muscular dystrophy 56
Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point 55
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 55
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 55
VOCAL CORD PARALYSIS IN CHARCOT-MARIE-TOOTH TYPE 4B1 DISEASE ASSOCIATED WITH A NOVEL MUTATION IN THE MYOTUBULARIN-RELATED PROTEIN 2 GENE: A CASE REPORT AND REVIEW OF THE LITERATURE 54
Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy 54
Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands 54
Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A 54
Loss of function MPZ mutation causes milder CMT1B neuropathy 53
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 53
POEMS syndrome: the matter-of-fact approach 53
Editorial: Current Insights Into LAMA2 Disease. 53
Foot pad skin biopsy in mouse models of hereditary neuropathy 53
Role of the extracellular matrix in regenerating and non-regenerating axonal neuropathies 52
Monophasic multifocal motor neuropathy with concomitant central nervous system demyelination following anti-TNFα therapy 52
CSN5/JAB1 REGULATES SCHWANN CELL-AXON INTERACTION AND PLAYS A ROLE IN PERIPHERAL NERVE DEVELOPMENT AND FUNCTION 51
How Schwann Cells Sort Axons: New Concepts 50
Diffuse intraneural leiomyoma in a case of sensorimotor neuropathy 50
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 50
Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures. 50
Totale 8.315
Categoria #
all - tutte 55.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202234 0 0 0 7 0 8 7 2 4 0 6 0
2022/2023269 98 49 22 0 3 23 12 14 11 31 1 5
2023/2024324 7 17 40 55 31 89 8 22 0 4 6 45
2024/20252.239 128 25 114 239 110 176 396 228 318 193 142 170
2025/20267.033 541 491 792 860 555 204 682 484 1.695 350 239 140
2026/2027731 257 474 0 0 0 0 0 0 0 0 0 0
Totale 10.669